Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-6 of 6
Keywords: Steroids
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Ophthalmic Research
Ophthalmic Res (2023) 66 (1): 599–610.
Published Online: 08 February 2023
...Manhong Xu; Xiaoe Fan; Xinyuan Huang; Xin Chen; Yan Shao; Xiaorong Li Introduction: The efficacy and influence of steroids for reducing the incidence of proliferative vitreoretinopathy (PVR) after rhegmatogenous retinal detachment (RRD) surgery remain controversial. Systematic review and meta...
Journal Articles
Subject Area:
Ophthalmology
Journal:
Ophthalmic Research
Ophthalmic Res (2019) 62 (4): 231–236.
Published Online: 02 May 2019
... growth factor (VEGF) agents are mostly chosen as a first-line treatment, there is an important role for steroids in the treatment algorithm for DME. A slow-release bioerodible dexamethasone implant and an extended-release nonbioerodible fluocinolone acetonide insert are both approved for the treatment...
Journal Articles
Subject Area:
Ophthalmology
Journal:
Ophthalmic Research
Ophthalmic Res (2015) 53 (4): 194–199.
Published Online: 09 April 2015
...Giuseppe Querques; Vittorio Capuano; Pietro Frascio; Francesco Bandello; Eric H. Souied Intravitreal injection of anti-VEGF drugs currently represents the standard of treatment for exudative age-related macular degeneration. Several therapeutic options including steroids, inhibitors of complement...
Journal Articles
Journal:
Ophthalmic Research
Ophthalmic Res (2014) 52 (2): 89–96.
Published Online: 29 August 2014
... administration of pharmacotherapies represents the standard of care for the treatment of this complication: anti-vascular endothelium growth factor agents and steroids are the drugs currently used for this aim. Differently from laser therapy, which prevents visual deterioration, the intravitreal approach allows...
Journal Articles
Subject Area:
Ophthalmology
Journal:
Ophthalmic Research
Ophthalmic Res (1997) 29 (4): 207–217.
Published Online: 11 December 2009
... consistently significantly associated with all forms of cataract: diabetes and raised plasma glucose (not in non-diabetics), use of steroid medication, raised levels of cortisol (steroid users excluded), albumin, alkaline phosphatase, γ-glutamyl transpeptidase, sodium and total protein and reduced levels...
Journal Articles
Subject Area:
Ophthalmology
Journal:
Ophthalmic Research
Ophthalmic Res (1990) 22 (5): 287–294.
Published Online: 10 December 2009
... in retina and optic nerve head. Marked changes were observed in blood flow in iris, ciliary processes, and choroid. Steroid treatment had no effect upon the increased blood flow 24 h after the endotoxin injection, although from a clinical standpoint the steroid-treated eyes appeared less inflamed...